Treatment-Induced Endocrine Confounding in Glioma Sex-Survival Differences: A Four-Mechanism Hypothesis

Read full text Summarise with VIRAT
Authors: Navaal Jagram, Nalini Jagram-Payer, Alysia Payer
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Sex-based survival differences in glioblastoma and high-grade gliomas are consistently observed across multiple clinical datasets, with premenopausal women showing a survival advantage that attenuates or reverses in postmenopausal cohorts. Despite this signal, hormone-modulating therapy trials have produced inconsistent results for over two decades. This manuscript proposes that part of this inconsistency arises from a treatment-induced endocrine confounding architecture that progressively dilutes the female survival signal during and after standard glioma treatment. Four interacting mechanisms are proposed to contribute: (1) treatment-induced premature ovarian insufficiency through gonadotoxic chemotherapy and radiation; (2) dilution of hormonally active female survival signals when premenopausal and postmenopausal patients are analyzed together; (3) possible biologic effects of abrupt estrogen withdrawal on residual tumor behavior; and (4) partial endocrine convergence in males during prolonged corticosteroid exposure. TCGA clinical data stratified by sex and menopausal status are included as supporting evidence. This framework suggests that prior hormone-related therapeutic studies may have underestimated biologic signal strength due to confounding introduced by the treatment itself, and proposes specific study designs to test each mechanism independently.

Fields of Study & Subjects

Glioma Diagnosis and Treatment Sex and Gender in Healthcare Ovarian cancer diagnosis and treatment

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
22 March 2026
Language
EN
Document type
Preprint